TG Therapeutics, Inc

Short Term Long Term Short Term Comparison Long Term Comparison
  • TGTX
  • 1d-0.64%
  • 1w-6.82%
  • 1m-7.56%
  • 1y-30.76%
ATH
  • ATH Price$233.44
  • ATH Date2010-05-04
  • % since ATH-93.97%
  • % to ATH1,559.12%
ATL
  • ATL Price$1.01
  • ATL Date2011-12-29
  • % from ATL1,289.63%
  • Last Low Price$1.0125
  • Last Low Date2011-12-29
  • % From Last Low1,289.63%
IPO
  • IPO Price$0.07
  • % Current ROI USD19,273.97%
  • ATH Price$233.44
  • % ROI ATH 2,305,560.49%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="TGTX"]

Key Data [addtoany]

Current price $14.07
Sector Healthcare
Industry Biotechnology
Today's High/Low $14.575/$13.945
Volume 2,269,057.00
Previous Close $14.16
52 Week High/Low $35.67/$6.46
Market Cap 2,186,601,216.00
P/E Ratio 157.333
Forward P/E 1 Yr. $140.85
Earnings Per Share(EPS) $0.48
Annualized Dividend $0
$14.07
[addtoany]
Annual Data | Millions of US $ except per share data
Cash on hand
Receivables
Inventory
Pre-Paid Expenses
Other Current Assets
Total Current Assets
Property, Plant, And Equipment
Long-Term Investments
Goodwill And Intangible Assets
Other Long-Term Assets
Total Long-Term Assets
Total Assets
Total Current Liabilities
Long Term Debt
Other Non-Current Liabilities
Total Long Term Liabilities
Total Liabilities
Common Stock Net
Retained Earnings (Accumulated Deficit)
Comprehensive Income
Other Share Holders Equity
Share Holder Equity
Total Liabilities And Share Holders Equity